Profitable Regenerative Therapies

Therapies that patients want + a system that turns curiosity or interest into accepted care!

Offer High Quality Wharton’s Jelly, Exosomes, and Peptides with confidence — all at great pricing. Our education-first SaaS also comes with affordable pricing and lifts typical case acceptance from 25–33% to 80–85%, trains staff, automates follow-up, and proves outcomes with real data.

Key Highlights:

  • Truly compliant Wharton’s Jelly.
  • 80–85% typical case acceptance rate with our SaaS.
  • 1M+ patient education report variations.
  • 3T/ml guaranteed exosome concentration.
  • Great pricing on all tissue products, peptides, and the SaaS platform.
Book A Discovery Call & Feel The Difference

Wharton’s Jelly Allografts

  • Truly first-generation cells with nothing added and nothing removed.
  • Processed to meet strict minimal manipulation requirements.
  • Designed to support joint health, soft tissue repair, and faster recovery.
  • High-value self-pay service patients ask for.
  • Offered at competitive pricing so your practice stays profitable.
See How Our Wharton’s Jelly Is Different

Exosomes

  • Not force-manufactured, preserving intact vesicles for maximum effectiveness.
  • Guaranteed minimum 3 trillion exosomes per milliliter.
  • Lyophilized for a two-year shelf life at room temperature.
  • Reconstitute with bacteriostatic water or Wharton’s Jelly for enhanced results.
  • Backed by great pricing to support the growth and scalability of your practice.
Learn Why All Exosomes Are Not Equal

Peptides

  • Support recovery, metabolic balance, sleep, cognition, and tissue repair.
  • Drive recurring revenue with monthly protocols and follow-ups.
  • Large addressable need (weight loss alone): 40% of adults are obese and 76% overweight.
  • Seamlessly integrated into education and CRM workflows.
  • More than 100 peptides available at excellent wholesale pricing that maximize margins.
Is High Quality & Low Price Really Possible?

The SaaS Differentiator
  • Plain-English patient education covering nearly all conditions and treatments.
  • Show progression without care, expected results with treatment, and annual cost of living with the condition.
  • Lift self-pay acceptance from 25–33% to 80–85% consistently.
  • Outcomes dashboard shows real improvements by specific condition and treatment.
  • Affordable monthly subscription designed for any practice size.
Want To See Our SaaS In Action?

Training & CRM Built for Medicine
  • Role-based training for front desk through provider.
  • Add your own videos, written modules, and multiple-choice quizzes.
  • Medical CRM with thousands of prebuilt education emails and texts.
  • Add your own content and custom workflows for complete control.
  • All included in our affordably priced SaaS platform.
Here’s An Example Of Our Training?

Proof & Compliance
  • Wharton’s Jelly is truly first-generation; nothing added, nothing removed.
  • Exosomes are lyophilized, intact, and not force-manufactured.
  • Peptides sourced under strict quality standards.
  • Designed to align with minimal manipulation requirements.

ROI Snapshot
  • 10 weekly WJ cases at $7,500 can add over $1.4M in annual profit.
  • Small and large practice models scale linearly with presentations.
  • Automated nurture reactivates old leads and past patients.
  • Proven systems + quality products turn interest into predictable revenue.
  • All supported by great pricing on products and SaaS.
Would You Like A Report Detailing The ROI?

Request a Demo
What You’ll See in the Demo:
  • Patient education reports with over 1M variations.
  • Condition-specific CRM workflows that convert.
  • Training center complete with team training or add-your-own modules and quizzes.
  • Outcomes dashboard that answers “How do I know it will work?”
Who It’s For:
  • Practices currently offering, or adding, Wharton’s Jelly, Exosomes, and Peptides.
  • Clinics seeking higher self-pay acceptance and recurring programs.
  • Teams that want training, automation, and measurable outcomes.
  • Leaders ready to reduce dependence on insurance reimbursements.
  • Doctors who want the best pricing on both products and SaaS.